Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use KRINTAFEL safely and effectively. See full prescribing information for KRINTAFEL. KRINTAFEL (tafenoquine) tablets, for oral useInitial U.S. Approval: 2018
Medication labelWhy this: Advisory · dailymed-prescription
KRINTAFEL is indicated for the radical cure (prevention of relapse) of Plasmodium vivax malaria in patients aged 16 years and older who are receiving chloroquine therapy for acute P. vivax infection [see Dosage and Administration (2.2)]. Limitations of Use •KRINTAFEL is NOT indicated for the treatment of acute P. vivax malaria. •Concomitant use of KRINTAFEL with antimalarials other than chloroquine is not recommended because of the risk of recurrence of P. vivax malaria [see Warnings and Precautions (5.6)].
- generic_name
- tafenoquine succinate
- product_names
- tafenoquine succinate
- ndc
- 0173-0889, 0173-0889-39
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en